Avidia

biopharmaceutical company

Avidia, Inc., a biopharmaceutical company, engages in discovering and developing therapeutic proteins. The company offers Avimer therapeutic proteins, which are used to address various therapeutic areas, including autoimmunity, inflammation,...

Founded in 2003
Homepage: http://www.avidia.com
Total money raised: $72.3M

HQ

94043 2450 Bayshore Parkway
2nd Floor
Mountain View
USA CA

Phone: 650-404-2000

Updated on Jul 2, 2010
Avidia at CrunchBase

October, 2008

Avidia was acquired by Amgen
for $380M

Amgen to buy inflammation drug co. Avidia for up to $380M

deals.venturebeat.com

May, 2006

Avidia raised $43.8M in a Series C round from Skyline Ventures, HealthCare Ventures, Alloy Ventures, Amgen Ventures, MedImmune Ventures, Morgenthaler Ventures, and Texas Pacific Group

AVIDIA RAISES $43.8 MILLION TO ADVANCE NEW CLASS OF PHARMACEUTICALS

May, 2005

Avidia raised $28.5M in a Series B round from MedImmune Ventures and Amgen Ventures

AVIDIA ADVANCING LEAD PRODUCT THROUGH $28.5M SERIES B ROUND.

thefreelibrary.com

2003

Avidia was founded in 2003